PE20061136A1 - Sistema de capsulas blandas que no son de gelatina - Google Patents

Sistema de capsulas blandas que no son de gelatina

Info

Publication number
PE20061136A1
PE20061136A1 PE2005001306A PE2005001306A PE20061136A1 PE 20061136 A1 PE20061136 A1 PE 20061136A1 PE 2005001306 A PE2005001306 A PE 2005001306A PE 2005001306 A PE2005001306 A PE 2005001306A PE 20061136 A1 PE20061136 A1 PE 20061136A1
Authority
PE
Peru
Prior art keywords
starch
hydroxypropylate
carragenin
gelatine capsules
encapsulation
Prior art date
Application number
PE2005001306A
Other languages
English (en)
Inventor
Rickey Shelley
Norman Stroud
Keith E Tanner
Elizabeth Youngblood
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Publication of PE20061136A1 publication Critical patent/PE20061136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE REFIERE A UN SISTEMA DE CAPSULA BLANDA QUE NO SON DE GELATINA QUE COMPRENDE: A) UNA ENVOLTURA QUE COMPRENDE i) UN ALMIDON MODIFICADO TAL COMO ALMIDON DE TAPIOCA HIDROXIPROPILADO, ALMIDON DE MAIZ HIDROXIPROPILADO, ENTRE OTROS, QUE TIENE UNA TEMPERATURA DE HIDRATACION INFERIOR A 90ºC, E ii) UNA CARRAGENINA GELIFICANTE TAL COMO IOTA-CARRAGENINA, KAPPA-CARRAGENINA O UNA MEZCLA DE ESTOS; LA RELACION PESO/PESO ENTRE EL ALMIDON Y LA CARRAGENINA ES ENTRE 1,5:1 Y 5:1, ADEMAS LA ENVOLTURA COMPRENDE AGUA, PLASTIFICANTE Y UN AMORTIGUADOR; Y B) UN RELLENO QUE TIENE UN pH MAYOR DE 7,5 QUE COMPRENDE i) UN PRINCIPIO ACTIVO DISUELTO O DISPERSO TAL COMO IBUPROFENO, NAPROXENO, ACETAMINOFEN, CLORHIDRATO DE PSEUDOEFEDRINA, ENTRE OTROS, ii) UN AGENTE ALCALINO CAPAZ DE NEUTRALIZAR HASTA EL 80% DEL PRINCIPIO ACTIVO ACIDO. DICHA COMPOSICION PERMITE LA ENCAPSULACION DE PRINCIPIOS ACTIVOS PREVIAMENTE CONSIDERADOS NO ADECUADOS PARA LA ENCAPSULACION EN CAPSULAS DE GELATINA TRADICIONAL
PE2005001306A 2004-11-08 2005-11-08 Sistema de capsulas blandas que no son de gelatina PE20061136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/984,205 US8231896B2 (en) 2004-11-08 2004-11-08 Non-gelatin soft capsule system

Publications (1)

Publication Number Publication Date
PE20061136A1 true PE20061136A1 (es) 2006-10-27

Family

ID=36316590

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001306A PE20061136A1 (es) 2004-11-08 2005-11-08 Sistema de capsulas blandas que no son de gelatina

Country Status (20)

Country Link
US (2) US8231896B2 (es)
EP (2) EP1809261B1 (es)
JP (1) JP5192816B2 (es)
AR (1) AR051237A1 (es)
AT (1) ATE536866T1 (es)
AU (1) AU2005305232B2 (es)
BR (1) BRPI0517674B8 (es)
CA (1) CA2585721C (es)
CY (1) CY1112518T1 (es)
DK (1) DK1809261T3 (es)
ES (2) ES2379970T3 (es)
HK (1) HK1108363A1 (es)
MX (1) MX2007005403A (es)
PE (1) PE20061136A1 (es)
PL (1) PL1809261T3 (es)
PT (1) PT1809261E (es)
SI (1) SI1809261T1 (es)
TW (1) TWI405592B (es)
UY (1) UY29200A1 (es)
WO (1) WO2006052452A1 (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
DK1993559T3 (en) 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
JP5021263B2 (ja) * 2006-10-02 2012-09-05 中日本カプセル 株式会社 皮膜用組成物
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
EP3225243A1 (en) 2007-04-25 2017-10-04 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
US20090004231A1 (en) * 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
WO2009073946A1 (en) * 2007-12-12 2009-06-18 Multi Formulations Ltd. Particles in a capsule
GB0801643D0 (en) * 2008-01-29 2008-03-05 Probio Nutraceuticals As Product
ES2954932T3 (es) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
BR112012005452B1 (pt) 2009-09-10 2021-05-11 DuPont Nutrition USA, Inc. cápsula de alginato sem costura, e, método para fabricar uma cápsula de alginato sem costura
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
EP2600849B1 (en) * 2010-08-04 2016-03-30 R.P. Scherer Technologies, LLC Film-forming composition for soft capsules
KR101411364B1 (ko) * 2012-03-16 2014-06-30 주식회사 서흥 전분을 주기재로 사용한 연질 캡슐 피막 조성물
EP2700415B1 (en) * 2011-04-20 2016-11-30 Suheung Co., Ltd. Non-animal soft capsule shell composition having improved disintegration and shell hardness
KR101294614B1 (ko) 2012-03-16 2013-08-08 주식회사 서흥캅셀 타피오카 변성전분을 주기재로 사용한 연질 캡슐 피막 조성물
KR101178842B1 (ko) * 2011-04-20 2012-09-03 주식회사 서흥캅셀 붕해도 및 피막 경도를 개선한 비동물성 연질 캡슐 피막 조성물
MX2015011163A (es) 2013-03-15 2016-02-17 Banner Life Sciences Llc Capsula entericas blandas que no contienen gelatina.
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
KR101445334B1 (ko) * 2013-06-05 2014-10-01 코스맥스바이오 주식회사 화학적 금속염을 포함하지 않는 식물성 연질캡슐조성물
JP5769760B2 (ja) * 2013-06-25 2015-08-26 アール．ピー． シェーラー テクノロジーズ エルエルシー ソフトカプセル用シェル形成組成物及びソフトカプセル
WO2015003109A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
WO2015059864A1 (ja) * 2013-10-25 2015-04-30 コニカミノルタ株式会社 粒子状肥料およびその製造方法
CN103495176B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种共混挤出法制备淀粉基软胶囊的方法
CN103550065B (zh) * 2013-10-26 2015-01-28 中山市凯博思淀粉材料科技有限公司 一种复合挤出法生产淀粉基软胶囊的方法
CN103520133B (zh) * 2013-10-26 2015-02-04 中山市凯博思淀粉材料科技有限公司 一种淀粉基软胶囊的制备方法
CN103893771B (zh) * 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种用于生产淀粉材料软胶囊的成膜组合物及其制备方法
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104337793A (zh) * 2014-10-16 2015-02-11 浙江春宝胶囊有限公司 一种非明胶软胶囊壳的配方
EP3380092B1 (en) * 2015-11-23 2021-12-29 Undoo, LLC Composition of olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body
JP6926453B2 (ja) * 2015-12-03 2021-08-25 大正製薬株式会社 カプセル組成物
IL290855B2 (en) 2016-03-28 2024-06-01 Eirgen Pharma Ltd Treatment methods using vitamin D
AU2017270219B2 (en) * 2016-05-25 2023-03-16 Tsi Group Co., Ltd. Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules
WO2018161054A1 (en) 2017-03-03 2018-09-07 Rgenix, Inc. Formulations with improved stability
US10711119B2 (en) 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
CA3148082A1 (en) * 2019-07-23 2021-01-28 R.P. Scherer Technologies, Llc Softshell capsule formulations, and methods of preparation and use thereof
KR20230165280A (ko) * 2021-04-01 2023-12-05 알.피.쉐러 테크놀러지즈 엘엘씨 제약 제제에서 음이온 킬레이트화제로서의 인지질
AU2021107198A4 (en) * 2021-08-24 2021-12-09 Blackmores Ltd A softgel capsule composition, and a process for producing a softgel capsule therefrom
EP4176724A1 (en) 2021-11-09 2023-05-10 Universität Hohenheim Use of an oleogel as a layer or coating
WO2024035911A1 (en) * 2022-08-12 2024-02-15 R.P. Scherer Technologies, Llc Fast dissolving softgel capsules

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2118040A (en) 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
JPS63164858A (ja) * 1986-12-27 1988-07-08 Unie Koroido Kk 軟カプセルの外皮
JPH0525037A (ja) 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
GB9226238D0 (en) * 1992-12-16 1993-02-10 Scherer Ltd R P Encapsulation apparatus and process
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5505961A (en) * 1993-08-05 1996-04-09 R. P. Scherer Corporation Gelatin capsules containing a highly concentrated acetaminophen solution
GB9705770D0 (en) 1997-03-20 1997-05-07 Scherer Corp R P Gelatin encapsulation techniques
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6387400B1 (en) * 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
US6884060B2 (en) * 2001-11-02 2005-04-26 R.P. Scherer Technologies, Inc. Apparatus for manufacturing encapsulated products
US7887838B2 (en) 2002-01-18 2011-02-15 Banner Pharmacaps, Inc. Non-gelatin film and method and apparatus for producing same
MXPA05002728A (es) * 2002-09-13 2005-07-25 Cydex Inc Capsulas que contienen composiciones de relleno acuoso estabilizadas con ciclodextrina derivada.
JP2004250369A (ja) * 2003-02-19 2004-09-09 Fuji Capsule Kk 軟カプセル剤皮膜組成物
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses

Also Published As

Publication number Publication date
JP2008519075A (ja) 2008-06-05
CA2585721A1 (en) 2006-05-18
MX2007005403A (es) 2007-05-16
SI1809261T1 (sl) 2013-09-30
EP2289496A2 (en) 2011-03-02
ES2603225T3 (es) 2017-02-24
DK1809261T3 (da) 2012-04-02
EP1809261B1 (en) 2011-12-14
CA2585721C (en) 2014-07-15
WO2006052452A1 (en) 2006-05-18
TWI405592B (zh) 2013-08-21
AU2005305232A1 (en) 2006-05-18
EP1809261A4 (en) 2008-09-10
BRPI0517674A (pt) 2008-10-14
AU2005305232B2 (en) 2010-03-25
BRPI0517674B8 (pt) 2021-05-25
EP2289496A3 (en) 2011-03-09
US20120269889A1 (en) 2012-10-25
EP2289496B1 (en) 2016-08-17
BRPI0517674B1 (pt) 2019-04-02
JP5192816B2 (ja) 2013-05-08
CY1112518T1 (el) 2015-12-09
HK1108363A1 (en) 2008-05-09
US8377470B2 (en) 2013-02-19
UY29200A1 (es) 2006-06-30
US20060099246A1 (en) 2006-05-11
EP1809261A1 (en) 2007-07-25
ES2379970T3 (es) 2012-05-07
ATE536866T1 (de) 2011-12-15
PL1809261T3 (pl) 2012-06-29
US8231896B2 (en) 2012-07-31
TW200630122A (en) 2006-09-01
PT1809261E (pt) 2012-04-11
AR051237A1 (es) 2006-12-27

Similar Documents

Publication Publication Date Title
PE20061136A1 (es) Sistema de capsulas blandas que no son de gelatina
DOP2012000217A (es) Pastillas de gelatina blanda con nicotina
AR094548A1 (es) Dispersión sólida físicamente estable
PE20181177A1 (es) Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas
AR052173A1 (es) Forma de dosificacion solida que comprende un inhibidor de bomba protonica y una suspension obtenida de la misma
PE88699A1 (es) Formas de dosificacion de liberacion sostenida de sertralina
PE20130589A1 (es) Composiciones y metodos para suministro al sistema nervioso central de arilsulfatasa a
PE20050175A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
PE20140960A1 (es) Formulaciones que comprenden un inhibidor de dpp4
NO20053681L (no) Dispersjon av smaksmaskerte krystaller eller granuler av aktive forbindelser, tyggbare blote kapsler fylt med nevnte dispersjon og fremgangsmate for fremstilling derav
WO2007143652A3 (en) Chewable soft gelatin capsules
AR058323A1 (es) Formulacion de suspension de fexofenadina
PE20001414A1 (es) Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
ES2720954T3 (es) Formulaciones estabilizadas de estatina
BRPI0707334A8 (pt) formulação de cápsula de gelatina mole e método para estabilização de um composto 15-ceto-prostaglandina
AR061011A1 (es) Suspension acuosa estable
PE20040105A1 (es) Capsulas para la higiene bucal
AR091039A1 (es) Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento
AR124044A1 (es) Cápsulas blandas de liberación retardada
UY37672A (es) Anillo vaginal para la liberación simultánea de dos ingredientes activos
PE20080673A1 (es) Formulaciones orales liofilizadas de desintegracion rapida de un antagonista del receptor de trombina
EA201170784A1 (ru) Гранулы тамсулозина для фиксированной комбинации
AR061165A1 (es) Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
AR122316A1 (es) Formulaciones de cápsulas de gel blando de origen no animal, métodos de preparación y métodos de uso de estas

Legal Events

Date Code Title Description
FC Refusal